Xencor to Host Analyst Day and Webcast on June 28, 2016 Read more about Xencor to Host Analyst Day and Webcast on June 28, 2016
Xencor Reports Complete Data Results from XmAb7195 Phase 1a Trial Showing Rapid Reduction of Serum IgE in High IgE Atopic Subjects at ATS 2016 International Conference Read more about Xencor Reports Complete Data Results from XmAb7195 Phase 1a Trial Showing Rapid Reduction of Serum IgE in High IgE Atopic Subjects at ATS 2016 International Conference
Xencor to Present at Upcoming Investor Conferences Read more about Xencor to Present at Upcoming Investor Conferences
Xencor Reports First Quarter 2016 Financial Results Read more about Xencor Reports First Quarter 2016 Financial Results
Xencor to Host First Quarter 2016 Financial Results Webcast and Conference Call on May 2, 2016 Read more about Xencor to Host First Quarter 2016 Financial Results Webcast and Conference Call on May 2, 2016
Xencor Reports Fourth Quarter and Full Year 2015 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2015 Financial Results
Xencor Initiates Two Phase 2 Trials of XmAb5871 in IgG4-Related Disease and Systemic Lupus Erythematosus Read more about Xencor Initiates Two Phase 2 Trials of XmAb5871 in IgG4-Related Disease and Systemic Lupus Erythematosus
Xencor to Present at Cowen and Company 36th Annual Health Care Conference Read more about Xencor to Present at Cowen and Company 36th Annual Health Care Conference
Xencor to Host Fourth Quarter and Full Year 2015 Financial Results Webcast and Conference Call on March 7, 2016 Read more about Xencor to Host Fourth Quarter and Full Year 2015 Financial Results Webcast and Conference Call on March 7, 2016
Xencor to Present at Two Upcoming Conferences in February Read more about Xencor to Present at Two Upcoming Conferences in February
